drugset / Trial / NCT01485211

Corneal Thickness Changes During Corneal Collagen Cross-linking With Ultraviolet-A Irradiation and Riboflavin

NCT01485211

Phase 4 Completed 18 enrolled Instituto de Olhos de Goiania
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the corneal pachymetric variations during and after corneal collagen cross-linking (CXL) treatment with ultraviolet-A irradiation (UVA) and hypo-osmolar riboflavin solution in thin corneas.

Timeline

Start
2010-01
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Riboflavin Other / unclassified 0.1 % Topical

Indications